This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by NEFF, M. S. Articles by SWARTZ, C. Search for Related Content PubMed PubMed Citation Articles by NEFF, M. S. Articles by SWARTZ, C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Anemia Hazardous Substances DB INDOCYANINE GREEN

(Circulation. 1971;43:876.)
© 1971 American Heart Association, Inc.

---

Hemodynamics of Uremic Anemia

MARTIN S. NEFF M.D.¹; KWAN E. KIM M.D.¹; MICHAEL PERSOFF M.D.¹; GADDO ONESTI M.D.¹; CHARLES SWARTZ M.D.¹

¹ From the Division of Nephrology and Vascular Diseases, Departments of Medicine, Hahnemann Medical College and Hospital, Philadelphia, Pennsylvania.

This study was undertaken to assess the importance of an elevated cardiac output in the generation of the hypertension associated with chronic renal failure. Forty stable uremic patients on a program of maintenance hemodialysis underwent hemodynamic studies. Cardiac index measured by dye dilution was found to be significantly elevated. Calculated peripheral vascular resistance was normal despite elevated blood pressure. Six patients underwent serial hemodynamic studies over a period of 6 to 12 weeks while being transfused with packed red blood cells to a normal hematocrit. Blood volume and body weight were constant during the study period. Cardiac index decreased during transfusion, reaching a normal level at a hematocrit of 30%. Diastolic blood pressure progressively rose, averaging an increase of 20 mm Hg at a hematocrit of 40%. Peripheral vascular resistance increased by 80% at a hematocrit of 40%.

We concluded that the elevation of cardiac index in uremic patients is secondary to anemia and is reversible when the hematocrit is raised over 30%. The high cardiac index is not responsible for hypertension because restoration of cardiac index to normal by transfusion raises blood pressure rather than lowers it.

Key Words: Cardiac output • Hypertension • Anemia • Hemodynamics • Uremia • Hemodialysis • Kidney

Submitted on December 9, 1970
Accepted on February 26, 1971

This article has been cited by other articles:

				J. L. Spivak and R. T. Silver The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal Blood, July 15, 2008; 112(2): 231 - 239. [Full Text] [PDF]

				S. Fishbane and A. Besarab Mechanism of Increased Mortality Risk with Erythropoietin Treatment to Higher Hemoglobin Targets Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1274 - 1282. [Abstract] [Full Text] [PDF]

				H. Schunkert and H.-W. Hense A heart price to pay for anaemia Nephrol. Dial. Transplant., March 1, 2001; 16(3): 445 - 448. [Full Text] [PDF]

				Z. Ni, X. Q. Wang, and N. D. Vaziri Nitric Oxide Metabolism in Erythropoietin-Induced Hypertension : Effect of Calcium Channel Blockade Hypertension, October 1, 1998; 32(4): 724 - 729. [Abstract] [Full Text] [PDF]

				E. D. Frohlich High Cardiac Output Hypertensions Angiology, July 1, 1976; 27(7): 475 - 485. [PDF]